Hepato‑Protection Effect of Curcumin Against Methylphenidate‑Induced Hepatotoxicity: Histological and Biochemical Evidences

Haleh Ahmadinasab, Majid Motaghinejad, Bahareh Arabzadeh Nosratabad, Seyedehnahal Bozorgniahosseini, Parastoo Rostami, Golbarg Shabani Jafarabadi, Manijeh Motevalian


Background: As a psychostimulant agent, methylphenidate (MPH) abuse can cause serious liver damage. Studies have documented the hepatoprotective impacts of curcumin on liver damage. According to this definition, the purpose of this study is to explain the hapatoprotective effects of curcumin against the hepatotoxicity induced by MPH. Methods: Seventy rats were equally divided into seven groups (10 rats per group). Groups 1 and 2 received normal saline (0.7 mL/rat) and MPH (10 mg/kg), respectively for 21 days. Groups 3, 4, 5, and 6 concurrently received MPH (10 mg/ kg) and curcumin (10, 20, 40, and 60 mg/kg, respectively) for 21 days. Group 7 was treated with curcumin (60 mg/kg) alone for 21 days. The hepatic function test key enzymes such as AST, ALP, and histology of liver tissue (ALT), and alkaline phosphatase (ALP) levels was studied in the blood samples, and also, the histopathological changes and cell density changes were evaluated in the liver tissue. Results: The latest studies have shown that the administration of MPH induces rises in the AST, ALT, and ALP levels and induces degeneration changes in histopathology, whereas curcumin administration at doses of 40 and 60 mg/kg reduced the elevation of MPH‑induced hepatic enzyme and inhibited histopathological degeneration in the MPH‑treated classes. Curcumin alone (60 mg/kg) did not alter the biochemical and histological parameters. Conclusions: Curcumin can function as a hepatoprotective agent against MPH‑induced hepatotoxicity.


Curcumin; hepatoprotective; methylphenidate

Full Text:



Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH,

Schneeweiss S. Psychosis with methylphenidate or amphetamine

in patients with ADHD. N Engl J Med 2019;380:1128‑38.

Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC,

Liechti ME. Pharmacological profile of methylphenidate‑based

designer drugs. Neuropharmacology 2018;134:133‑40.

Shellenberg TP, Stoops WW, Lile JA, Rush CR. An update on

the clinical pharmacology of methylphenidate: Therapeutic

efficacy, abuse potential and future considerations. Expert Rev

Clin Pharmacol 2020;13:825‑33.

Fekete S, Romanos M, Gerlach M. [Does methylphenidate cause

liver damage? An analysis of ad hoc reports to the “Bundesinstitut

für Arzneimittel und Medizinprodukte (BfArM)”]. Z Kinder

Jugendpsychiatr Psychother 2018;46:342‑8.

Schelleman H, Bilker WB, Kimmel SE, Daniel GW,

Newcomb C, Guevara JP, et al. Methylphenidate and risk

of serious cardiovascular events in adults. Am J Psychiatry


Motaghinejad M, Motevalian M, Shabab B. Effects of chronic

treatment with methylphenidate on oxidative stress and

inflammation in hippocampus of adult rats. Neurosci Lett


Alam N, Ikram R. Methylphenidate‑induced hepatotoxicity in rats

and its reduction by buspirone. Pak J Pharm Sci 2018;31:741‑5.

Lewis JJ, Iezzoni JC, Berg CL. Methylphenidate‑induced

autoimmune hepatitis. Dig Dis Sci 2007;52:594‑7.

Vera‐Ramirez L, Pérez‐Lopez P, Varela‐Lopez A,

Ramirez‐Tortosa M, Battino M, Quiles JL. Curcumin and liver

disease. Biofactors 2013;39:88‑100.

Reyes‑Gordillo K, Shah R, Lakshman M, Flores‑Beltrán R,

Muriel P. Hepatoprotective properties of curcumin. Liver

Pathophysiology. Amsterdam; 2017. p. 687‑704.

Mohanty I, Arya DS, Dinda A, Joshi S, Talwar KK, Gupta SK.

Protective effects of Curcuma longa on ischemia‑reperfusion

induced myocardial injuries and their mechanisms. Life Sci


Motaghinejad M, Karimian M, Motaghinejad O, Shabab B,

Yazdani I, Fatima S. Protective effects of various dosage of

curcumin against morphine induced apoptosis and oxidative stress

in rat isolated hippocampus. Pharmacol Rep 2015;67:230‑5.

Motaghinejad M, Bangash MY, Hosseini P, Karimian SM,

Motaghinejad O. Attenuation of morphine withdrawal

syndrome by various dosages of curcumin in comparison

with clonidine in mouse: Possible mechanism. Iran J Med Sci


Dattani J, Rajput D, Moid N, Highland H, George L, Desai K.

Ameliorative effect of curcumin on hepatotoxicity induced

by chloroquine phosphate. Environ Toxicol Pharmacol


Naik SR, Thakare VN, Patil SR. Protective effect of curcumin

on experimentally induced inflammation, hepatotoxicity and

cardiotoxicity in rats: Evidence of its antioxidant property. Exp

Toxicol Pathol 2011;63:419‑31.

Somanawat K, Thong‑Ngam D, Klaikeaw N. Curcumin

attenuated paracetamol overdose induced hepatitis. World J

Gastroenterol 2013;19:1962‑7.

Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin

in middle cerebral artery occlusion induced focal cerebral

ischemia in rats. Life Sci 2004;74:969‑85.

Motaghinejad M, Bangash MY, Motaghinejad O. Attenuation

of alcohol withdrawal syndrome and blood cortisol level with

forced exercise in comparison with diazepam. Acta Med Iran


Jevtovic‑Todorovic V, Hartman RE, Izumi Y, Benshoff ND,

Dikranian K, Zorumski CF, et al. Early exposure to common

anesthetic agents causes widespread neurodegeneration in the

developing rat brain and persistent learning deficits. J Neurosci


Nixon K, Crews FT. Binge ethanol exposure decreases

neurogenesis in adult rat hippocampus. J Neurochem


Khokhar N. Serum aminotransferase levels and platelet count as

predictive factor of fibrosis and cirrhosis in patients with chronic

hepatitis C infection. J Pak Med Assoc 2003;53:101‑3.

Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T.

Serum aminotransferase levels and platelet counts as predictors

of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001;96:3142‑6.

Sahay A, Hen R. Adult hippocampal neurogenesis in depression.

Nat Neurosci 2007;10:1110‑5.

Motaghinejad M, Motevalian M. Involvement of AMPA/kainate

and GABA A receptors in topiramate neuroprotective effects

against methylphenidate abuse sequels involving oxidative stress

and inflammation in rat isolated hippocampus. Eur J Pharmacol


Raoofi A, Delbari A, Mahdian D, Mojadadi M‑S, Amini A,

Javadinia SS, et al. Toxicology of long‐term and high‑dose

administration of methylphenidate on the kidney tissue–a

histopathology and molecular study. Toxicol Mech Methods


Giannini EG, Testa R, Savarino V. Liver enzyme alteration:

A guide for clinicians. CMAJ 2005;172:367‑79.

Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The

current state of serum biomarkers of hepatotoxicity. Toxicology